To explore the potential roles of IFN-γ in the expression of PD-1, PBMCs from healthy controls were treated with unexposed elder plasma or convalescent COVID-19 plasma in combination with IFN-γ neutralization antibody or isotype control antibody. This evidence concerns the gene PDCD1 and COVID-19.